(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1316398 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC41A2 mRNA CTD PMID:22079256 1,2-dichloroethane increases expression ISO RGD:1550688 6480464 ethylene dichloride results in increased expression of SLC41A2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1550688 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC41A2 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1550688 6480464 Estradiol results in increased expression of SLC41A2 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC41A2 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1550688 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316398 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC41A2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550688 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC41A2 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550688 6480464 Tetrachlorodibenzodioxin affects the expression of SLC41A2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550688 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC41A2 mRNA CTD PMID:21889950 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC41A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC41A2 mRNA CTD PMID:19692669 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC41A2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of SLC41A2 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of SLC41A2 mRNA CTD PMID:21346803 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC41A2 mRNA CTD PMID:25825206 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC41A2 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC41A2 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1316398 6480464 Aflatoxin B1 results in decreased expression of SLC41A2 mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:1316398 6480464 Aflatoxin B1 results in decreased methylation of SLC41A2 gene CTD PMID:27153756 aflatoxin M1 decreases expression ISO RGD:1316398 6480464 Aflatoxin M1 results in decreased expression of SLC41A2 mRNA CTD PMID:30928695 all-trans-retinoic acid increases expression ISO RGD:1316398 6480464 Tretinoin results in increased expression of SLC41A2 mRNA CTD PMID:23724009 amiodarone decreases expression ISO RGD:1550688 6480464 Amiodarone results in decreased expression of SLC41A2 mRNA CTD PMID:24535564 benzo[a]pyrene decreases expression ISO RGD:1550688 6480464 Benzo(a)pyrene results in decreased expression of SLC41A2 mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO RGD:1316398 6480464 Benzo(a)pyrene results in increased methylation of SLC41A2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550688 6480464 Benzo(a)pyrene results in increased expression of SLC41A2 mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550688 6480464 Diethylhexyl Phthalate results in increased expression of SLC41A2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1550688 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC41A2 mRNA] CTD PMID:19850644 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC41A2 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1316398 6480464 bisphenol A results in increased expression of SLC41A2 mRNA CTD PMID:31715268 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC41A2 mRNA CTD PMID:25181051 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of SLC41A2 mRNA CTD PMID:24136188 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of SLC41A2 mRNA CTD PMID:22110744 calcitriol increases expression ISO RGD:1316398 6480464 Calcitriol results in increased expression of SLC41A2 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1316398 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC41A2 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1550688 6480464 Nanotubes, Carbon analog results in increased expression of SLC41A2 mRNA, Nanotubes, Carbon results in increased expression of SLC41A2 mRNA CTD PMID:25554681 , PMID:25620056 carbonyl cyanide p-trifluoromethoxyphenylhydrazone increases expression EXP 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of SLC41A2 mRNA CTD PMID:27157538 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of SLC41A2 mRNA CTD PMID:18500788 chromium(6+) decreases expression ISO RGD:1316398 6480464 chromium hexavalent ion results in decreased expression of SLC41A2 mRNA CTD PMID:30690063 cyclosporin A increases expression ISO RGD:1316398 6480464 Cyclosporine results in increased expression of SLC41A2 mRNA CTD PMID:20106945 , PMID:25562108 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC41A2 mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:1550688 6480464 Diclofenac results in increased expression of SLC41A2 mRNA CTD PMID:26934552 dioxygen multiple interactions ISO RGD:1550688 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC41A2 mRNA CTD PMID:30529165 dopamine increases expression EXP 6480464 Dopamine results in increased expression of SLC41A2 mRNA CTD PMID:21983523 doxorubicin decreases expression ISO RGD:1316398 6480464 Doxorubicin results in decreased expression of SLC41A2 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1316398 6480464 entinostat results in increased expression of SLC41A2 mRNA CTD PMID:27188386 fenoldopam increases expression EXP 6480464 Fenoldopam results in increased expression of SLC41A2 mRNA CTD PMID:21983523 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC41A2 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC41A2 mRNA CTD PMID:24793618 furan increases expression ISO RGD:1550688 6480464 furan results in increased expression of SLC41A2 mRNA CTD PMID:24183702 furan decreases expression EXP 6480464 furan results in decreased expression of SLC41A2 mRNA CTD PMID:25539665 , PMID:26194646 glafenine increases expression EXP 6480464 Glafenine results in increased expression of SLC41A2 mRNA CTD PMID:24136188 lead(0) affects expression ISO RGD:1316398 6480464 Lead affects the expression of SLC41A2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1316398 6480464 Lead affects the expression of SLC41A2 mRNA CTD PMID:28903495 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC41A2 mRNA CTD PMID:30467583 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC41A2 mRNA CTD PMID:27157538 nickel atom increases expression ISO RGD:1316398 6480464 Nickel results in increased expression of SLC41A2 mRNA CTD PMID:24768652 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of SLC41A2 mRNA CTD PMID:23439660 ozone increases expression ISO RGD:1316398 6480464 Ozone results in increased expression of SLC41A2 mRNA CTD PMID:28652203 paracetamol affects expression ISO RGD:1550688 6480464 Acetaminophen affects the expression of SLC41A2 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1550688 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of SLC41A2 mRNA] CTD PMID:29246445 paracetamol increases expression ISO RGD:1550688 6480464 Acetaminophen results in increased expression of SLC41A2 mRNA CTD PMID:29246445 paracetamol increases expression ISO RGD:1316398 6480464 Acetaminophen results in increased expression of SLC41A2 mRNA CTD PMID:22230336 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLC41A2 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:1550688 6480464 Phenobarbital results in decreased expression of SLC41A2 mRNA CTD PMID:19270015 , PMID:19482888 phenobarbital affects expression ISO RGD:1550688 6480464 Phenobarbital affects the expression of SLC41A2 mRNA CTD PMID:23091169 phenobarbital affects expression ISO RGD:1316398 6480464 Phenobarbital affects the expression of SLC41A2 mRNA CTD PMID:19159669 pirinixic acid multiple interactions ISO RGD:1550688 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC41A2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1550688 6480464 pirinixic acid results in decreased expression of SLC41A2 mRNA CTD PMID:23811191 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC41A2 mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:1550688 6480464 pirinixic acid results in increased expression of SLC41A2 mRNA CTD PMID:17426115 potassium chromate multiple interactions ISO RGD:1316398 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC41A2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1316398 6480464 potassium chromate(VI) results in decreased expression of SLC41A2 mRNA CTD PMID:22079256 , PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550688 6480464 Pregnenolone Carbonitrile results in increased expression of SLC41A2 mRNA CTD PMID:27413110 progesterone increases expression ISO RGD:1316398 6480464 Progesterone results in increased expression of SLC41A2 mRNA CTD PMID:20864642 quercetin decreases expression ISO RGD:1316398 6480464 Quercetin results in decreased expression of SLC41A2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1550688 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC41A2 mRNA] CTD PMID:31298478 ritodrine increases expression ISO RGD:1550688 6480464 Ritodrine results in increased expression of SLC41A2 mRNA CTD PMID:23370008 silicon dioxide decreases expression ISO RGD:1316398 6480464 Silicon Dioxide analog results in decreased expression of SLC41A2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1550688 6480464 Silicon Dioxide results in increased expression of SLC41A2 mRNA CTD PMID:23221170 Soman increases expression EXP 6480464 Soman results in increased expression of SLC41A2 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:1316398 6480464 Sunitinib results in increased expression of SLC41A2 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1316398 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC41A2 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1316398 6480464 Testosterone results in increased expression of SLC41A2 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1550688 6480464 Carbon Tetrachloride affects the expression of SLC41A2 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1550688 6480464 Carbon Tetrachloride results in increased expression of SLC41A2 mRNA CTD PMID:31919559 titanium dioxide multiple interactions ISO RGD:1550688 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SLC41A2 mRNA] CTD PMID:31298478 titanium dioxide decreases expression ISO RGD:1550688 6480464 titanium dioxide results in decreased expression of SLC41A2 mRNA CTD PMID:31298478 trichostatin A increases expression ISO RGD:1316398 6480464 trichostatin A results in increased expression of SLC41A2 mRNA CTD PMID:24935251 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of SLC41A2 mRNA CTD PMID:24136188 urethane increases expression ISO RGD:1316398 6480464 Urethane results in increased expression of SLC41A2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1550688 6480464 Valproic Acid results in decreased expression of SLC41A2 mRNA CTD PMID:24535564 valproic acid increases expression ISO RGD:1316398 6480464 Valproic Acid results in increased expression of SLC41A2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:1316398 6480464 Valproic Acid results in decreased methylation of SLC41A2 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1316398 6480464 Valproic Acid affects the expression of SLC41A2 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1550688 6480464 Vancomycin results in decreased expression of SLC41A2 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC41A2 mRNA CTD PMID:23869203 
Gene Ontology Annotations
